These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 778939)

  • 21. [Clinical test of noxiptilin in the scope of cooperative testing in 5 psychiatric hospitals].
    Eckmann F; Immich H; Neumann H; Schäpperle O; Schwarz H; Tempel H
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:893+. PubMed ID: 4895493
    [No Abstract]   [Full Text] [Related]  

  • 22. First-episode schizophrenia: the importance of early intervention and subjective tolerability.
    Kasper S
    J Clin Psychiatry; 1999; 60 Suppl 23():5-9. PubMed ID: 10625193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of thiothixene in acute newly admitted schizophrenic patients.
    Ngui PW; Teo SH
    Singapore Med J; 1971 Aug; 12(4):227-32. PubMed ID: 5129906
    [No Abstract]   [Full Text] [Related]  

  • 24. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G; Safadi G; Beauclair L
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical considerations in the use of risperidone.
    Remington GJ
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S96-100. PubMed ID: 7504575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher than usual dosage of haloperidol: a pilot study in chronic schizophrenics.
    Pacquay M; Brasseur F
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):46-9. PubMed ID: 798190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 28. The risks and benefits of clozapine versus chlorpromazine.
    Claghorn J; Honigfeld G; Abuzzahab FS; Wang R; Steinbook R; Tuason V; Klerman G
    J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of therapeutic responsivity to thiothixene in schizophrenics.
    Sterlin C; Oliveros R; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):394-6. PubMed ID: 4882603
    [No Abstract]   [Full Text] [Related]  

  • 30. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics.
    Hicks PB; Vinogradov S; Riney SJ; Su K; Csernansky JG
    J Clin Psychopharmacol; 1989 Jun; 9(3):209-12. PubMed ID: 2567742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An uncontrolled clinical study with clomacran in newly admitted schizophrenic patients.
    Torres-Ruiz A; Nieto D; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):6-7. PubMed ID: 329331
    [No Abstract]   [Full Text] [Related]  

  • 33. Flexeril--a new muscle relaxant.
    Med Lett Drugs Ther; 1978 Jan; 20(2):12. PubMed ID: 339050
    [No Abstract]   [Full Text] [Related]  

  • 34. Naltrexone in chronic schizophrenia. Results of a clinical trial.
    Ragheb M; Berney S; Ban T
    Int Pharmacopsychiatry; 1980; 15(1):1-5. PubMed ID: 6993401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multi-centre general practitioner assessment of butriptyline hydrochloride ('Evadyne').
    Kapadia AP; Smith SM
    Curr Med Res Opin; 1976; 4(4):278-84. PubMed ID: 1036481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new antidepressant butriptyline: plasma levels and clinical response.
    Burrows GD; Norman TR; Maguire KP; Rubinstein G; Scoggins BA; Davies B
    Med J Aust; 1977 Oct; 2(18):604-6. PubMed ID: 579645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noxiptylin and masked depression.
    Sacchetti E; Smeraldi E; Bellodi L; Bottinelli S; Altamura C
    Agressologie; 1978; 19(1):59-63. PubMed ID: 581535
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
    Meltzer HY; Paul SM; Fang VS
    Psychopharmacology (Berl); 1977 Jan; 51(2):181-3. PubMed ID: 14352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Butaclamol hydrochloride in newly admitted schizophrenics.
    Hollister LE; Davis KL; Berger PA
    Psychopharmacol Commun; 1975; 1(5):493-500. PubMed ID: 778939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of butaclamol in chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    J Clin Pharmacol; 1977; 17(8-9):529-36. PubMed ID: 19510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.